70 related articles for article (PubMed ID: 18453861)
21. New finding on immune response to HIV Tat may contribute to vaccine, treatment.
James JS
AIDS Treat News; 2000 Sep; (351):4. PubMed ID: 12173551
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Delta that expresses SIV Gag protein.
Suzuki H; Kidokoro M; Fofana IB; Ohashi T; Okamura T; Matsuo K; Yamamoto N; Shida H
Vaccine; 2009 Feb; 27(7):966-71. PubMed ID: 19135118
[TBL] [Abstract][Full Text] [Related]
23. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
Peut V; Kent SJ
Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
[TBL] [Abstract][Full Text] [Related]
24. Frequency of the major histocompatibility complex Mamu-A*01 allele in a closed breeding colony of rhesus monkey (Macaca mulatta) from Brazil.
Andrade MC; Leite JP; Cabello PH
J Med Primatol; 2009 Feb; 38(1):39-41. PubMed ID: 19018945
[TBL] [Abstract][Full Text] [Related]
25. Within-host evolution of CD8+-TL epitopes encoded by overlapping and non-overlapping reading frames of simian immunodeficiency virus.
Hughes AL; Piontkivska H; Krebs KC; O'Connor DH; Watkins DI
Bioinformatics; 2005 Nov; 21 Suppl 3():iii39-44. PubMed ID: 16306391
[TBL] [Abstract][Full Text] [Related]
26. A common rhesus macaque MHC class I molecule which binds a cytotoxic T-lymphocyte epitope in Nef of simian immunodeficiency virus.
Horton H; Rehrauer W; Meek EC; Shultz MA; Piekarczyk MS; Jing P; Carter DK; Steffen SR; Calore B; Urvater JA; Vogel TU; Wilson NA; Watkins DI
Immunogenetics; 2001 Jul; 53(5):423-6. PubMed ID: 11486280
[No Abstract] [Full Text] [Related]
27. Gradual adaptation of HIV to human host populations: good or bad news?
Brander C; Walker BD
Nat Med; 2003 Nov; 9(11):1359-62. PubMed ID: 14595431
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.
Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM
Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380
[TBL] [Abstract][Full Text] [Related]
29. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
30. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
[TBL] [Abstract][Full Text] [Related]
31. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
[TBL] [Abstract][Full Text] [Related]
32. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
33. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
34. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
[TBL] [Abstract][Full Text] [Related]
35. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
36. Immunity in natural SIV infections.
Silvestri G
J Intern Med; 2009 Jan; 265(1):97-109. PubMed ID: 19093963
[TBL] [Abstract][Full Text] [Related]
37. An immuno-logic hypothesis.
Kohler H; Muller S
J Med Primatol; 2002 Aug; 31(4-5):311-2. PubMed ID: 12390548
[No Abstract] [Full Text] [Related]
38. Toward improved evaluation of cytotoxic T-lymphocyte (CTL)-inducing HIV vaccines in Thailand.
Ariyoshi K; Promadej N; Ruxrungtham K; Sutthent R
AIDS Res Hum Retroviruses; 2002 Jul; 18(10):737-9. PubMed ID: 12167283
[No Abstract] [Full Text] [Related]
39. Duesberg vindicated? Not yet.
Palca J
Science; 1991 Oct; 254(5030):376. PubMed ID: 1925593
[No Abstract] [Full Text] [Related]
40. A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein.
Bonci F; Zabogli E; Freer G; Merico A; Bendinelli M; Pistello M
Vet Immunol Immunopathol; 2008 May; 123(1-2):150-3. PubMed ID: 18304654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
